Provention Bio, Inc. — Operating Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/f95351a4-849b-46cb-8dde-cbbf5995ae17/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-128.2M | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-009516 |
| FY 2021 | $-115.6M | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-005304 |
| FY 2020 | $-99.7M | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-004781 |
| FY 2019 | $-44.4M | 2019-01-01 – 2019-12-31 | evidence 0001493152-20-003770 |
| FY 2018 | $-26.8M | 2018-01-01 – 2018-12-31 | evidence 0001493152-19-003588 |
| FY 2017 | $-9.1M | 2017-01-01 – 2017-12-31 | evidence 0001493152-19-003588 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).